Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ – Avadel Pharmaceuticals (NASDAQ:AVDL), iShares Biotechnology ETF (NASDAQ:IBB) 2025-01-09T07:30:05-05:00January 9th, 2025| share this article![#item_full_content] Read More share this article! Related Posts Why Axon Could Be the Best Stock to Buy in January @themotleyfool #stocks $AXON $^GSPC January 9th, 2025 ‘Shark Tank’s’ Kevin O’Leary and billionaire Frank McCourt want to buy TikTok. One problem: It’s not for sale January 9th, 2025 Ohio Adopts The Uniform Public Expression Protection Act As Its First Anti-SLAPP Law January 9th, 2025 Jimmy Carter Funeral: Ex-VP’s Son Reportedly Cuts Line Criticizing Treatment Of Immigrants—With Trump In Attendance (Live Updates) January 9th, 2025
